STAT

For the first time, U.S. panel recommends screening adults for illicit drug use

The U.S. Preventive Services Task Force says it's a good idea for doctors to ask their adult patients about illicit drug use when effective treatment and care are available.
With effective treatments for for addiction, such as methadone, it's now time to screen adults for illicit drug use, says the U.S. Preventive Services Task Force.

As new ways to identify and treat people who use opioids and other drugs emerge, an independent panel of experts is recommending that health care providers screen their adult patients for illicit drug use.

The U.S. Preventive Services Task Force has determined, for the first time, that there is enough evidence to state with “moderate certainty” that screening adults for illicit substance use is overall beneficial.

What the panel means by “screening” means a physician asking a patient a series of questions. The answers can indicate who might need to be offered or referred support. It does not include drug testing. “Screening tools are not meant to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks